Advanced search
Publication Cover
Cancer Management and Research Volume 13, 2021 - Issue
Submit an article Journal homepage
101
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Encouraging Pathological Complete Response Rate from Neoadjuvant Chemotherapy with Albumin-Bound Paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Esophageal Squamous Carcinoma: Preliminary Outcome of a Retrospective Study

Wen Zhang1 Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People’s Republic of China
,
Yong Li2 Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People’s Republic of China
,
Liyan Xue3 Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-5185-0126
ORCID Icon,
Dong Qu4 Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People’s Republic of China
,
Zhichao Jiang1 Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-0092-1494
ORCID Icon,
Zhen Wang2 Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People’s Republic of China
,
Zhaoyang Yang3 Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People’s Republic of China
&
Aiping Zhou1 Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 2163-2170 | Published online: 02 Mar 2021

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Fang Yan, Longpei Chen, Mingzhen Ying, Jie Li & Qiang Fu. (2024) Efficacy and Safety of Pembrolizumab Combined with Albumin-Bound Paclitaxel and Nedaplatin for Advanced Esophageal Squamous Cell Carcinoma. Immunotherapy 16:5, pages 305-317.
Read now

Articles from other publishers (7)

Hui-Jun Wang, Jun-Jie Lu, Ling-Fang Hao, Hai-Na Li, Na LiWei-Hua Zheng & Jun-Jing Zhang. (2023) Squamous cell carcinoma of the cystic duct: A case report and literature review. Medicine 102:41, pages e35430.
Crossref
Zheng ZhaoMing-Mei YinWei-Feng ZhaoChao-Jie Wang. (2023) The efficacy and safety of sintilimab combined with chemotherapy as the first-line treatment for metastatic esophageal squamous cell carcinoma. Medicine 102:33, pages e34794.
Crossref
Yong Li, Aiping Zhou, Shuoyan Liu, Ming He, Keneng Chen, Ziqiang Tian, Yin Li, Jianjun Qin, Zhen Wang, Haiquan Chen, Hui Tian, Yue Yu, Wang Qu, Liyan Xue, Shun He, Shuhang Wang, Fenglong Bie, Guangyu Bai, Bolun Zhou, Zhaoyang Yang, Huiyao Huang, Yan Fang, Benjamin Li, Xiangrong Dai, Shugeng Gao & Jie He. (2023) Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial. BMC Medicine 21:1.
Crossref
Jiakuan Chen, Jianfei Zhu, Yan ZhangWenchen Wang, Yanmin Xia, Jinbo Zhao & Tao Jiang. (2023) Efficacy of albumin-bound paclitaxel combined with nedaplatin in neoadjuvant therapy for esophageal squamous cell carcinoma: A single-center retrospective observational study. Medicine 102:9, pages e33157.
Crossref
Zhichao Tian, Shuping Dong, Yang Yang, Shilei Gao, Yonghao Yang, Jinpo Yang, Peng Zhang, Xin Wang & Weitao Yao. (2022) Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: a retrospective study. BMC Cancer 22:1.
Crossref
Dan Han, Baosheng Li, Qian Zhao, Hongfu Sun, Jinling Dong, Shaoyu Hao & Wei Huang. (2022) The Key Clinical Questions of Neoadjuvant Chemoradiotherapy for Resectable Esophageal Cancer—A Review. Frontiers in Oncology 12.
Crossref
Wenzhong Wang, Yang Yi, Yinghui Jia, Xiaoxin Dong, Junxia Zhang, Xiaomeng Song & Yan Song. (2022) Neoadjuvant chemotherapy with liposomal paclitaxel plus platinum for locally advanced esophageal squamous cell cancer: Results from a retrospective study. Thoracic Cancer 13:6, pages 824-831.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.